Abstract
ALTHOUGH it is widely accepted that glutamate may be a significant central transmitter (for reviews, see refs 1 and 2), definitive neuropharmacological evidence at the synaptic level has not been forthcoming, and studies with proposed glutamate antagonists3–6 have yielded anomalous results. On the basis of biochemical evidence, however7, glutamate fulfils many of the criteria expected of a neurotransmitter; in particular, nerve endings8 and glia9,10 possess high-affinity transport systems for glutamate, which it is thought, in common with other amino acid neurotransmitters, are responsible for terminating its synaptic actions. For these high-affinity systems to function, there is a stringent requirement for sodium11, which may be involved in the initial binding phase at the reuptake site, prior to transport12–14. Until recently, very little attention has been paid to the possibility of investigating directly the biochemical properties of postsynaptic amino acid receptors. Young and Snyder15 have demonstrated that strychnine, a potent and selective antagonist of glycine-induced hyperpolarisations of spinal neurones, binds specifically to a component of synaptic membranes; this is probably the physiological glycine receptor since strychnine has negligible affinity for the glycine high-affinity uptake system. The specific γ-aminobutyric acid (GABA) antagonist, bicuculline, has also been found to competitively inhibit GABA binding to synaptosomes, in which the uptake site had been inactivated by chlorpromazine16. In both these cases, binding to the postsynaptic receptor was not affected by the absence of sodium.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Johnson, J. L., Brain Res., 37, 1–19 (1972).
Hammerschlag, R., and Weinreich, D., Biochem. Psychopharmac., 6, 165–180 (1972).
McLennan, H., Marshall, K. C., and Huffman, R. D., Experientia, 27, 1116 (1971).
Haldeman, S., and McLennan, H., Brain Res., 45, 393–400 (1972).
Curtis, D. R., Duggan, A. W., Felix, D., Johnston, G. A. R., Tebēcis, A. K., and Watkins, J. C., Brain Res., 41, 283–301 (1972).
Davies, J., and Watkins, J. C., Brain Res., 59, 311–322 (1973).
Snyder, S. H., Young, A. B., Bennett, J. P., and Mulder, A. H., Fedn Proc., 32, 2039–2047 (1973).
Logan, W. J., and Snyder, S. H., Brain Res., 42, 413–431 (1972).
Schrier, B. K., and Thompson, E. J., J. biol. Chem., 249, 1769–1781 (1974).
Roberts, P. J., and Keen, P., J. Neurochem., 23, 201–209 (1974).
Bennett, J. P., Logan, W. J., and Snyder, S. H., J. Neurochem., 21, 1533–1550 (1973).
Varon, S., Weinstein, H., Kakefuda, K., and Roberts, E., Biochem. Pharmac., 14, 1213–1224 (1965).
DeFeudis, F. V., Life Sci., 11, 743–748 (1972).
Shiu, P. C., and Elliot, K. A. C., Can. J. Biochem. Physiol., 51, 121–128 (1973).
Young, A. B., and Snyder, S. H., Proc. natn. Acad. Sci. U.S.A., 70, 2832–2836 (1973).
Peck, E. J., jun., Schaeffer, J. M., and Clark, J. H., Biochem. biophys. Res. Commun., 52, 394–400 (1973).
Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J., J. biol. Chem., 193, 265–275 (1951).
Curtis, D. R., and Watkins, J. C., J. Physiol., 166, 1–14 (1963).
Balcar, V. J., and Johnston, G. A. R., J. Neurobiol., 3, 295–301 (1972).
Balcar, V. J., and Johnston, G. A. R., J. Neurochem., 19, 2657–2666 (1972).
Roberts, P. J., and Watkins, J. C., Brain Res. (in the press).
Curtis, D. R., Duggan, A. W., and Johnston, G. A. R., Expl Brain Res., 10, 447–462 (1970).
Kleinzeller, A., and Cort, J. H., Biochem. J., 67, 15–24 (1957).
Webb, J. L., in Enzyme and Metabolic Inhibitors, Vol II, 729–986 (Academic Press, New York, 1966).
Lunt, G. G., Comp. gen. Pharmac., 4, 75–79 (1973).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
ROBERTS, P. Glutamate receptors in the rat central nervous system. Nature 252, 399–401 (1974). https://doi.org/10.1038/252399a0
Received:
Issue Date:
DOI: https://doi.org/10.1038/252399a0
This article is cited by
-
Excitatory sulphur amino acid-evoked neurotransmitter release from rat brain synaptosome fractions
Journal of Neural Transmission (1989)
-
Inhibition by excitatory sulphur amino acids of the high-affinityl-glutamate transporter in synaptosomes and in primary cultures of cortical astrocytes and cerebellar neurons
Neurochemical Research (1989)
-
Association of [14C]glutamate with the protein components of synaptic membrane preparations
Neurochemical Research (1985)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.